EXHIBIT 31.2


CERTIFICATION  PURSUANT  TO  SECTION  302  OF  THE  SARBANES-OXLEY  ACT  OF 2002
- --------------------------------------------------------------------------------

     I, M. Dwight Cantrell, certify that:

1.   I  have  reviewed  this  quarterly report on Form 10-QSB of Endovasc, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a  material  fact  or  omit  to state a material fact necessary to make the
     statements  made, in light of the circumstances under which such statements
     were  made,  not  misleading  with  respect  to  the period covered by this
     report;

3.   Based  on  my  knowledge,  the  financial  statements,  and other financial
     information  included  in  this  report,  fairly  present  in  all material
     respects  the  financial condition, results of operations and cash flows of
     Endovasc,  Inc.  as  of,  and  for,  the  periods presented in this report;

4.   Endovasc,  Inc.'s  other  certifying  officer  and  I  are  responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)) for Endovasc, Inc. and have:

     (a)  Designed  such  disclosure  controls  and  procedures,  or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure  that material information relating to Endovasc, Inc., including its
     consolidated  subsidiaries,  is  made  known  to  us by others within those
     entities,  particularly  during  the  period  in which this report is being
     prepared;

     (b) Evaluated the effectiveness of Endovasc, Inc.'s disclosure controls and
     procedures  and  presented  in  this  report  our  conclusions  about  the
     effectiveness  of  the disclosure controls and procedures, as of the end of
     the  period  covered  by  this  report  based  on  such  evaluation;  and

     (c)  Disclosed  in  this  report  any  change  in Endovasc, Inc.'s internal
     control over financial reporting that occurred during Endovasc, Inc.'s most
     recent fiscal quarter that has materially affected, or is reasonably likely
     to  materially  affect,  Endovasc,  Inc.'s  internal control over financial
     reporting;  and

5.   Endovasc,  Inc.'s  other  certifying officer and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     Endovasc, Inc.'s auditors and the audit committee of Endovasc, Inc.'s board
     of  directors  (or  persons  performing  the  equivalent  functions):

     (a)  All  significant deficiencies and material weaknesses in the design or
     operation of internal control over financial reporting which are reasonably
     likely  to  adversely  affect  Endovasc, Inc.'s ability to record, process,
     summarize  and  report  financial  information;  and

     (b)  Any  fraud, whether or not material, that involves management or other
     employees  who have a significant role in Endovasc, Inc.'s internal control
     over  financial  reporting.

Date:  May 24, 2004                 By: /s/ M. Dwight Cantrell
                                        ----------------------
                                        M. Dwight Cantrell
                                        Chief Financial Officer


                                       21